Guggenheim Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Guggenheim Capital’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,420	Closed	-$29K	–	3076
2015 Q1	$29K	Buy	4,420 +399	+10%	+$2.73K	﹤0.01%	2974
2014 Q4	$26K	Buy	4,021 +1,553	+63%	+$12.5K	﹤0.01%	2956
2014 Q3	$24K	Sell	2,468 -252	-9%	-$2.69K	﹤0.01%	2962
2014 Q2	$31K	Sell	2,720 -223	-8%	-$2.4K	﹤0.01%	3130
2014 Q1	$36K	Sell	2,943 -468	-14%	-$5.98K	﹤0.01%	3173
2013 Q4	$43K	Buy	3,411 +304	+10%	+$4.84K	﹤0.01%	3073
2013 Q3	$52K	Buy	3,107 +315	+11%	+$5.28K	﹤0.01%	2933
2013 Q2	$42K	Buy	+2,792	New	+$42.4K	﹤0.01%	2924

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $677M AUM 57.21% 1-Year Est. Return

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return